Hyperbaric Oxygen Ameliorates The Expression of Tumor Growth Factor-β and Malondialdehyde in Pristane-induced Lupus Nephritis Mice Model

Soetjipto Soetjipto, Indri Dwi Murbani, Titut Harnanik


BACKGROUND: Lupus nephritis (LN) is associated with chronic renal failure and a high mortality rate. Tumor growth factor-β (TGF-β) plays a basic part in keeping up immune homeostasis, meanwhile extensive oxidation of the lipid membrane in LN causes the arrangement of malondialdehyde (MDA). Up to date, the mechanism of hyperbaric oxygen (HBO) therapy in LN has not been elucidated well. Hence this study was conducted to assess the impact of HBO therapy on TGF-β and MDA expression in the pristane-induced LN mice model.

METHODS: Thirty-two mice aged 8-12 old weeks were isolated into 4 groups: normal saline-injected mice (group 1); pristane-injected mice (group 2); as well as pristane-injected followed by HBO-exposured with 2.4 (group 3) and 1.5 (group 4) atmosphere absolute (ATA) pressure. Pristane were injected intraperitoneal to initiate LN. Two months after pristane injection, the mice were placed within 24 hours in the special cage for metabolic examination to determined that pristane-induced LN mice model was successfully formed and marked by the occurring proteinuria. Oxidative stress was assessed by examining MDA, while systemic inflammation was assessed by examining by TGF-β. MDA and TGF-β serum were measured by enzyme-linked immunosorbent assay (ELISA).

RESULTS: A significantly lower (p<0.050) MDA expression was found in group 3 in comparison with group 2. The results also showed that TGF-β level was significantly increased (p<0.050) in group 3 compared to group 2.

CONCLUSION: HBO therapy ameliorates inflammation in LN by diminishing MDA and expanding TGF-β levels through activating antioxidants.

KEYWORDS: lupus nephritis, hyperbaric oxygen, malondialdehyde, tumor growth factor-β

Full Text:



Parikh SV, Almaani S, Brodsky S, Rovin BH. Update on lupus nephritis: core curriculum 2020. Am J Kidney Dis. 2020; 76(2): 265–81, CrossRef.

Selvaraja M, Abdullah M, Arip M, Chin VK, Shah A, Nordin SA. Elevated interleukin-25 and its association to Th2 cytokines in systemic lupus erythematosus with lupus nephritis. PLoS One. 2019; 14(11): e0224707, CrossRef.

Almaani S, Meara A, Rovin BH. Update on lupus nephritis. Clin J Am Soc Nephrol. 2017; 12(5): 825–35, CrossRef.

Obrișcă B, Sorohan B, Tuță L, Ismail G. Advances in lupus nephritis pathogenesis: from bench to bedside. Int J Mol Sci. 2021; 22(7): 3766, CrossRef.

Caster DJ, Powell DW. Utilization of biomarkers in lupus nephritis. Adv Chronic Kidney Dis. 2019; 26(5): 351–9, CrossRef.

Morell M, Pérez-Cózar F, Marañón C. Immune-related urine biomarkers for the diagnosis of lupus nephritis. Int J Mol Sci. 2021; 22(13): 7143, CrossRef.

Pravda J. Systemic lupus erythematosus: pathogenesis at the functional limit of redox homeostasis. Oxid Med Cell Longev. 2019; 2019: 1651724, CrossRef.

Lightfoot YL, Blanco LP, Kaplan MJ. Metabolic abnormalities and oxidative stress in lupus. Curr Opin Rheumatol. 2017; 29(5): 442–9, CrossRef.

Chen PM, Wilson PC, Shyer JA, Veselits M, Steach HR, Cui C, et al. Kidney tissue hypoxia dictates T-cell mediated injury in murine lupus nephritis. Sci Transl Med. 2020; 12(538): eaay1620, CrossRef.

Chen F, Yan H, Yang F, Cheng L, Zhang S, Li S, et al. Evaluation of renal tissue oxygenation using blood oxygen level-dependent magnetic resonance imaging in chronic kidney disease. Kidney Blood Press Res. 2021; 46(4): 441–51, CrossRef.

Li D, Shi G, Wang J, Zhang D, Pan Y, Dou H, et al. Baicalein ameliorates pristane-induced lupus nephritis via activating Nrf2/HO-1 in myeloid-derived suppressor cells. Arthritis Res Ther. 2019; 21(1): 105, CrossRef.

Komai T, Inoue M, Okamura T, Morita K, Iwasaki Y, Sumitomo S, et al. Transforming growth factor-β and interleukin-10 synergistically regulate humoral immunity via modulating metabolic signals. Front Immunol. 2018; 9: 1364, CrossRef.

Yamamoto K, Loskutoff DJ. Expression of transforming growth factor-β and tumor necrosis factor-α in the plasma and tissues of mice with lupus nephritis. Lab Inves. 2000; 80(10): 1561–70, CrossRef.

Saxena V, Lienesch DW, Zhou M, Azhar M, Doetschman T, Singh RR, et al. Dual roles of immunoregulatory cytokine TGF- β in the pathogenesis of autoimmunity-mediated organ damage. J Immunol. 2008; 180(3): 1903–12, CrossRef.

Morales E, Galindo M, Trujillo H, Praga M. Update on lupus nephritis : looking for a new vision. Nephron. 2021; 145(1): 1–13, CrossRef.

Jin T, Almehed K, Carlsten H, Elia HF. Decreased serum levels of TGF- b 1 are associated with renal damage in female patients with systemic lupus erythematosus. Lupus. 2012; 21(3): 310–8, CrossRef.

Menyawi MEL, Fawzy M, Habib M, Shaker O. Serum transforming growth factor-beta 1 level in Egyptian systemic lupus erythematosus patients. Arch Rheumatol. 2018; 33(3): 358–66, CrossRef.

Wang T, Mei Y, Li Z. Research progress on regulatory B cells in systemic lupus erythematosus. Biomed Res Int. 2019; 2019: 7948687, CrossRef.

Moulton VR, Suarez-Fueyo A, Meidan E, Li H, Mizui M, Tsokos GC. Pathogenesis of human systemic lupus erythematosus: a cellular perspective. Trends Mol Med. 2017; 23(7): 615–35, CrossRef.

Xing Q, Su H, Cui J, Wang B. Role of Treg cells and TGF-β 1 in patients with systemic lupus erythematosus : a possible relation with lupus nephritis. Immunol Invest. 2012; 41(1): 15–27, CrossRef.

Li W, Deng C, Yang H, Wang G. The regulatory T cell in active systemic lupus erythematosus patients: A systemic review and meta-analysis. Front Immunol. 2019; 10: 159, CrossRef.

Parawansah, Sudayasa IP, Noor A, Syarifin K, Eso A, Ode W, et al. Momordica charantia L. fruit fractions inhibit malondialdehyde level and regenerate hepatic damage of hyperglycemic rats. Indones Biomed J. 2020; 12(1): 57–61, CrossRef.

Shah D, Mahajan N, Sah S, Nath SK, Paudyal B. Oxidative stress and its biomarkers in systemic lupus erythematosus. J Biomed Sci. 2014; 21(1): 23, CrossRef.

Olex-Zarychta D. Hyperbaric oxygenation as adjunctive therapy in the treatment of sudden sensorineural hearing loss. Int J Mol Sci. 2020; 21(22): 8588, CrossRef.

Memar MY, Yekani M, Alizadeh N, Baghi HB. Hyperbaric oxygen therapy: antimicrobial mechanisms and clinical application for infections. Biomed Pharmacother. 2019; 109: 440–7, CrossRef.

Choudhury R. Hypoxia and hyperbaric oxygen therapy: a review. Int J Gen Med. 2018; 11: 431–42, CrossRef.

Paprocki J, Pawlowska M, Sutkowy P, Piechocki J, Wo A. Evaluation of oxidative stress in patients with difficult-to-heal skin wounds treated with hyperbaric oxygen. Oxid Med Cell Longev. 2020; 2020: 1835352, CrossRef.

Sureda A, Batle JM, Martorell M, Capó X, Tejada S, Tur JA, et al. Antioxidant response of chronic wounds to hyperbaric oxygen therapy. PLoS One. 2016; 11(9): e0163371, CrossRef.

Bocci V, Valacchi G. Nrf2 activation as target to implement therapeutic treatments. Front Chem. 2015; 3: 4, CrossRef.

Song K, Chen J, Ding J, Xu H, Xu H, Qin Z. Hyperbaric oxygen suppresses stemness-associated properties and Nanog and oncostatin M expression, but upregulates β-catenin in orthotopic glioma models. J Int Med Res. 2020; 48(3): 300060519872898, CrossRef.

Benkő R, Miklós Z, Ágoston VA, Ihonvien K, Répás C, Csépányi-Kömi R, et al. Hyperbaric oxygen therapy dampens inflammatory cytokine production and does not worsen the cardiac function and oxidative state of diabetic rats. Antioxidants. 2019; 8(12): 607, CrossRef.

Xiang L, Liu A, Xu G. Expression of XBP1s in B lymphocytes is critical for pristane-induced lupus nephritis in mice. Am J Physiol - Ren Physiol. 2020; 318(5): F1258–70, CrossRef.

Lin Y, Yan Y, Zhang H, Chen Y, He Y, Wang S, et al. Salvianolic acid alleviates renal injury in systemic lupus erythematosus induced by pristane in BALB/c mice. Acta Pharm Sin B. 2017; 7(2): 159–66, CrossRef.

Bonomini F, Dos Santos M, Veronese FV, Rezzani R. NLRP3 inflammasome modulation by melatonin supplementation in chronic pristane-induced lupus nephritis. Int J Mol Sci. 2019; 20(14): 3466, CrossRef.

Pan Q, Chen X, Liao S, Chen X, Zhao C, Xu YZ, et al. Updated advances of linking psychosocial factors and sex hormones with systemic lupus erythematosus susceptibility and development. PeerJ. 2019; 7: e7179, CrossRef.

Körpınar Ş, Uzun H. The effects of hyperbaric oxygen at different pressures on oxidative stress and antioxidant status in rats. Medicina (Kaunas). 2019; 55(5): 205, CrossRef.

Kadariswantiningsih IN, Thaha M, Nugroho CW, Alsagaff MY, Santoso D, Empitu MA, et al. Could complete blood count parameters and non-fasting cholesterol profile describe inflammation and oxidative stress in chronic kidney disease? Indones Biomed J. 2018; 10(3): 270–7, CrossRef.

Khairani AF, Atik N, Halleyana P, Rahman A, Rohmawaty E, Noviyanti C, et al. Purple sweet potato yogurt affects lipid metabolism and reduces systemic inflammation and oxidative stress in high fat diet mice. Indones Biomed J. 2022; 14(3): 252–60, CrossRef.

Liang F, Kang N, Li P, Liu X, Li G, Yang J. Effect of hyperbaric oxygen therapy on polarization phenotype of rat microglia after traumatic brain injury. Front Neurol. 2021; 12: 640816, CrossRef.

Ou JN, Wiedeman AE, Stevens AM. TNF-α and TGF-β counter-regulate PD-L1 expression on monocytes in systemic lupus erythematosus. Sci Rep. 2012; 2: 295, CrossRef.

DOI: https://doi.org/10.18585/inabj.v15i1.2084

Copyright (c) 2023 The Prodia Education and Research Institute

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


Indexed by:






The Prodia Education and Research Institute